A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
Massimo Aglietta(Candiolo Cancer Institute), Carlo Barone(Università Cattolica del Sacro Cuore), M. B. Sawyer(University of Alberta), M.J. Moore(University of Toronto), W. H. Miller(McGill University), Cinzia Bagalá(Università Cattolica del Sacro Cuore), Federica Colombi(Candiolo Cancer Institute), Celeste Cagnazzo(Candiolo Cancer Institute), L. Gioeni(Candiolo Cancer Institute), Edward Wang(Pfizer (United States)), Bo Huang(Pfizer (United States)), K. Fly(Pfizer (United States)), Francesco Leone(Candiolo Cancer Institute)
Cited by 220Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis